McIlrath & Eck’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
McIlrath & Eck's OGN Position: Q1 2026 in Review
McIlrath & Eck reduced its Organon & Co (OGN) stake by 2.6% in Q1 2026, selling an estimated $53 and leaving 264 shares worth $1.58K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.
McIlrath & Eck first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $15K in Q1 2022. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- McIlrath & Eck held 264 shares of Organon & Co worth $1.58K as of Q1 2026.
- McIlrath & Eck sold 7 Organon & Co shares in Q1 2026, an estimated $53.
- Organon & Co made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1446 holding.
- McIlrath & Eck first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- McIlrath & Eck's Organon & Co position peaked at $15K in Q1 2022.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.